O
Oncozenge AB
F:8LY
Oncozenge AB
F:8LY
Price:
0.661
EUR
3.93%
Market Closed
Market Cap:
€7.7m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Oncozenge AB
F:8LY
|
SE |
|
WidePoint Corp
F:ZMX1
|
US |
|
Foresight Group Holdings Ltd
F:9LR
|
UK |
|
Godrej Properties Ltd
BSE:533150
|
IN |
|
Infroneer Holdings Inc
F:96L
|
JP |
|
Q
|
Qiagen NV
XMUN:QIA
|
NL |
|
G
|
Genco Shipping & Trading Ltd
F:GNU1
|
US |
|
Genco Shipping & Trading Ltd
NYSE:GNK
|
US |
|
Sitowise Group Oyj
F:1FT
|
FI |
|
Infroneer Holdings Inc
TSE:5076
|
JP |
|
N
|
Neodecortech SpA
F:FM2
|
IT |
Wall St Price Targets
8LY Price Targets Summary
Oncozenge AB
Oncozenge AB
Wall Street analysts forecast 8LY stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for 8LY is 0.764 EUR with a low forecast of 0.757 EUR and a high forecast of 0.787 EUR.
Lowest Forecast
Price Target
0.757
EUR
14% Upside
Average Forecast
Price Target
0.764
EUR
16% Upside
Highest Forecast
Price Target
0.787
EUR
19% Upside
Oncozenge AB Competitors:
Price Targets
Price Targets
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is 8LY's stock price target?
Price Target
0.764
EUR
0.764
EUR
According to Wall Street analysts, the average 1-year price target for 8LY is 0.764 EUR with a low forecast of 0.757 EUR and a high forecast of 0.787 EUR.
What is the Revenue forecast for Oncozenge AB?
Projected CAGR
93%
93%
The compound annual growth rate for Revenue over the next 1 year is 93%.
